Guidance Document for Industry - Review of Drug Brand Names
To provide market authorization holders direction on the process to be followed and information to be submitted to Health Canada regarding the potential for a proposed name to be misleading or confused with another product authorized for use in Canada with the aim of preventing medication errors.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance Document for Industry - Review of Drug Brand NamesHTMLEnglish publication HTML
-
Guidance Document for Industry - Review of Drug Brand NamesHTMLFrench publication HTML
Similar records